Millennium Management »

Acelyrin shares owned by Millennium Management

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Millennium Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $27M 4.0M 6.75
2023-09-30 $348k 34k 10.17
2023-06-30 $15M 732k 20.90

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors Put Option (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices Call Option (AMD)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Broadcom (AVGO)

View all positions for Millennium Management

Top funds holding Acelyrin

Citadel Advisors
FMR
Vanguard Group
BlackRock
Millennium Management
OrbiMed Advisors
venBio Partners
Adage Capital Partners GP
General Atlantic
Blue Owl Capital Holdings
Jpmorgan Chase & Co
Samsara BioCapital
Artal Group
T. Rowe Price Investment Management
Franklin Resources

View all funds holding Acelyrin